J. Dirschinger

发表

[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].

A. Kastrati, J. Mehilli, J. Dirschinger, 2012, Vestnik rentgenologii i radiologii.

Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2001, Circulation.

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, Journal of the American College of Cardiology.

Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, JAMA.

Predictive factors of restenosis after coronary stent placement.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1997, Journal of the American College of Cardiology.

Restenosis after coronary placement of various stent types.

K Ulm, A. Kastrati, J. Mehilli, 2001, The American journal of cardiology.

Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss

Jörg Hausleiter, Adnan Kastrati, Albert Schömig, 2006, Circulation.

Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement.

Jörg Hausleiter, Adnan Kastrati, Albert Schömig, 2004, American heart journal.

Intracoronary stenting and risk for major adverse cardiac events during the first month.

M. Hadamitzky, J. Hausleiter, A. Kastrati, 1998, Circulation.

A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries

J. Hausleiter, A. Kastrati, J. Mehilli, 2004, Journal of internal medicine.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, The New England journal of medicine.

Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi.

Stephan G Nekolla, Markus Schwaiger, Albert Schömig, 2005, Journal of the American College of Cardiology.

Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, Circulation.

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, JAMA.

Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Clopidogrel therapy in patients undergoing coronary stenting: Value of a high‐loading‐dose regimen

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, JAMA.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003 .

Clinical and angiographic follow‐up after balloon angioplasty with provisional stenting for coronary in‐stent restenosis

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

M. Schwaiger, A. Kastrati, J. Mehilli, 2006, JAMA.

Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2000, Journal of the American College of Cardiology.

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, The New England journal of medicine.

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2009, Circulation.

Statin treatment following coronary artery stenting and one-year survival.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Journal of the American College of Cardiology.

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, Clinical Research in Cardiology.

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

A. Kastrati, J. Dirschinger, F. Neumann, 1998, Circulation.

Incidence of Restenosed Coronary Lesions after PTCA Analysis of Possibly Meaningful Factors

E. Fleck, J. Dirschinger, W. Rudolph, 1986 .

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Early Administration of Reteplase Plus Abciximab vs Abciximab Alone in Patients With Acute Myocardial Infarction Referred for Percutaneous Coronary Intervention

Jamie D. Feusner, F. Goodwin, E. O’Brien, 2004 .

Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.

Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, JAMA.

Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2007, American heart journal.

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2002, Lancet.

Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: A randomized double‐blind controlled trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

M. Hadamitzky, J. Hausleiter, A. Kastrati, 1997, Circulation.

A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, American heart journal.

Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, Journal of the American College of Cardiology.

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2010, Clinical Research in Cardiology.

Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, The American journal of cardiology.

Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2011, Clinical Research in Cardiology.

Myocardial Salvage after Reduced-Dose Thrombolysis Combined with Glycoprotein IIb/IIIa Blockade Versus Thrombolysis Alone in Patients with Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of Thrombosis and Thrombolysis.

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen.

A. Kastrati, J. Dirschinger, J. Pache, 2001, Journal of the American College of Cardiology.

Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.

A. Kastrati, J. Dirschinger, J. Pache, 2001, The American journal of cardiology.

Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The American journal of cardiology.

Restenosis after balloon dilatation of coronary stenosis, multivariate analysis of potential risk factors.

E. Fleck, J. Dirschinger, W. Rudolph, 1988, European heart journal.

Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high load

A. Kastrati, J. Mehilli, J. Dirschinger, 1997, American heart journal.

Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial

M. Hadamitzky, M. Schwaiger, A. Kastrati, 2010, Circulation. Cardiovascular interventions.

Restenosis in one lesion in patients with multilesion stenting occurs even when the companion lesion is free of restenosis

Adnan Kastrati, Albert Schömig, A. Kastrati, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.

S. Steinhubl, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, American heart journal.

Clinical comparison of nitrates and sydnonimines.

J. Dirschinger, W. Rudolph, 1991, European heart journal.

Risk factor analysis for the 30-day outcome after coronary stent implantation in patients with acute myocardial infarction

A. Kastrati, J. Dirschinger, F. Neumann, 1998 .

When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?

J. Dirschinger, A. Beyerle, G. Reiniger, 1988, European heart journal.

Clinical and angiographic outcome after stent placement for chronic coronary occlusion.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1998, The American journal of cardiology.

Influence of Various Percutaneous Coronary Interventional Devices on Postinterventional Luminal Shape and Plaque Surface Characteristics as Determined by Intravascular Ultrasound

J. Dirschinger, M. Roffi, L. Finci, 2003 .

Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

Treatment of Myocardial Ischemia with Nitrates

J. Dirschinger, W. Rudolph, F. Kraus, 1990 .

Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon.

M. Schwaiger, A. Kastrati, J. Dirschinger, 2001, The American journal of cardiology.

Risk factor analysis for stent occlusion within the first month after successful coronary stent placement

J. Hausleiter, A. Kastrati, J. Dirschinger, 1998 .

CLINICAL RESEARCH Interventional Cardiology Influence of Treatment Duration With a 600-mg Dose of Clopidogrel Before Percutaneous Coronary Revascularization

S. Steinhubl, A. Kastrati, J. Mehilli, 2004 .

[Significance of coronary artery calcification: relationship to localization and severity of coronary artery stenosis (author's transl)].

E. Fleck, J. Dirschinger, W. Rudolph, 1978, Herz.

Is high pressure inflation necessary for optimal stenting

A. Kastrati, J. Dirschinger, J. Pache, 1998 .

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, JAMA.

McLeod syndrome: a distinct form of neuroacanthocytosis

A. Danek, J. Dirschinger, M. Reiter, 1992, Journal of Neurology.

Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

M. Schwaiger, A. Kastrati, J. Mehilli, 2000, The New England journal of medicine.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Journal of the American College of Cardiology.

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, JAMA.

One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, European heart journal.

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2009, Journal of the American College of Cardiology.

CLINICAL RESEARCH Interventional Cardiology A Randomized Trial Comparing Myocardial Salvage Achieved by Coronary Stenting Versus Balloon Angioplasty in Patients With Acute Myocardial Infarction Considered Ineligible for Reperfusion Therapy

Adnan Kastrati, Markus Schwaiger, Albert Schömig, 2004 .

Gender and restenosis after coronary artery stenting.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, European heart journal.

Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1997, Journal of the American College of Cardiology.

Genetic risk factors and restenosis after percutaneous coronary interventions

A. Kastrati, J. Dirschinger, A. Schömig, 2000, Herz.

Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis.

A. Kastrati, J. Dirschinger, F. Neumann, 2000, American heart journal.

CLINICAL RESEARCH Acute Coronary Syndromes Gender and Myocardial Salvage After Reperfusion Treatment in Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, JAMA.

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Adnan Kastrati, Albert Schömig, Melchior Seyfarth, 2008, Journal of the American College of Cardiology.

Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation.

P. Boekstegers, G. Steinbeck, A. Kastrati, 1999, Circulation.

Lesion Types Correlating with High Incidence of Complications after PTCA

J. Dirschinger, W. Rudolph, S. Dacian, 1991 .

A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease

A. Kastrati, J. Mehilli, J. Dirschinger, 2000 .

Vessel size and long-term outcome after coronary stent placement.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1998, Circulation.

Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, The American journal of medicine.

Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, The American journal of cardiology.

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2002, The Lancet.

Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, European heart journal.

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The New England journal of medicine.

Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR‐DIRECT trial)

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, Circulation.

Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, The American journal of cardiology.

Influence of lesion length on restenosis after coronary stent placement.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1999, The American journal of cardiology.

Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction

S. Nekolla, M. Schwaiger, J. Dirschinger, 2005 .

Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, American heart journal.

Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of medicine.

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1998, Journal of the American College of Cardiology.

Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement.

A. Kastrati, J. Dirschinger, H. Schühlen, 1997, Circulation.

Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, Circulation.

Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients

P. Boekstegers, G. Steinbeck, A. Kastrati, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis

A. Kastrati, J. Mehilli, J. Dirschinger, 2005 .

Comparative in‐vitro validation of eight first- and second‐generation quantitative coronary angiography systems

A. Kastrati, J. Dirschinger, J. Hausleiter, 1997, Coronary artery disease.

Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

A. Kastrati, J. Dirschinger, H. Schühlen, 1998, Circulation.

Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Journal of the American College of Cardiology.

A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, Circulation.

Coronary Artery Disease Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main

A. Kastrati, J. Dirschinger, M. Seyfarth, 2009 .

Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.

J. Dirschinger, W. Rudolph, 1985, American heart journal.

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of cardiology.

[Effects of antianginal agents on myocardial blood flow].

E. Fleck, J. Dirschinger, W. Rudolph, 1982, Herz.

Effectiveness of interval nitrate therapy in angina pectoris.

J. Dirschinger, W. Rudolph, D. Hall, 1989, European heart journal.

[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].

J. Dirschinger, W. Rudolph, 1981, Herz.

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2009, Circulation.

A randomized trial comparing the hand‐mounted JoStent with the premounted Multi‐Link Duet stent in patients with coronary artery disease

A. Kastrati, J. Mehilli, J. Dirschinger, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, JAMA.

[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].

A. Kastrati, J. Mehilli, J. Dirschinger, 2012, Vestnik rentgenologii i radiologii.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004 .

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.